Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

View source ↗

Summary

An update on a Daewoong trial evaluating Olostar Tab for improving systolic blood pressure and LDL-C versus conventional treatments, including medication conven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olostar Tab

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hyperlipidemias, Hypertension | Status: ACTIVE_NOT_RECRUITING